PMI A Story of Innovation - Episode 4 thumbnail

PMI: A Story of Innovation

Episode 4: "No way back"
The reaction inside PMI after André Calantzopoulos, our then CEO, publicly announced that the company will phase out cigarettes. Also, we discuss our historic FDA application to authorize IQOS as a modified risk tobacco product.

Watch now
PMI_IR23CoverImage_Desktop_1404x543px

Integrated Report 2023

PMI is transforming for good
Read more
JPG-800width-PMI Science Cube

PMI announces ambition to become a more than two-thirds majority smoke-free company by 2030

4 min read Discover more
People walking in an office

Delivering a smoke-free future

We’re building PMI’s future on smoke-free products that—while not risk-free—are a far better choice than cigarette smoking.
2 min read Find out more

Our progress toward a smoke-free future as of Q3 2024

 1 As of June 30, 2024. 2 As of December 31, 2023. Important Note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated October 22, 2024, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our Investor Relations pages. “PMI” refers to Philip Morris International Inc. and its subsidiaries. 


Our Science
Cutting-edge research and technology
Tobacco plants
A burning match

The problem with burning

Exploring the science behind combustion.
3 min read Learn all about it

 

For all our latest news and views

Subscribe to the PMI corporate newsletter

 

 

Leaders of Change
PMI’s thought leaders share their insights and expertise
Dr Moira Gilchrist, Chief Communication Officer, Philip Morris International

Businesspeople should think more like scientists, where failures present opportunities for solutions

A life in science has taught me that knockbacks are a necessary step on the path to success, writes Dr Moira Gilchrist.
3 min read Read more
Empty chairs in an auditorium

Our leadership team

Discover more
Make history
Develop your career at PMI
Job-opportunities-article-highlight-crop-gradient-left

Make history with us

Search our job opportunities
Work with us

How we #MakeHistory by creating better choices

Music starts.

Elodie Ly, Lead Life Sciences Projects, Switzerland, talks to camera.

Our team of more than 400 world-class scientists, engineers and technicians are constantly working towards offering current adult smokers a better choice than continuing to smoke cigarettes.

Music ends

Words appear on screen:

Hashtag Make History

Find out more at PMI.com.

 


 
Philip Morris International logo

Why invest in PMI?

We are investing behind innovation and delivering sustainable growth from our leading smoke-free products, which are a much better choice than continued smoking.

$12624

1.99 (1.60%)

Investor Relations

Latest news & press releases

Media Center
  • Press release 22 Oct, 2024

    Philip Morris International Reports 2024 Third-Quarter & First Nine-Months Results; Raises 2024 Guidance for Reported Diluted EPS to $6.20 - $6.26 and Adjusted Diluted EPS to $6.45 - $6.51

  • Press release 18 Oct, 2024

    Court-Appointed Mediator Proposes CCAA Plan to Resolve Tobacco Product-Related Claims and Litigation in Canada

  • Press release 15 Oct, 2024

    Philip Morris International to Host Webcast of 2024 Third-Quarter and First Nine-Months Results

  • Press release 17 Sep, 2024

    Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex

This site is operated for the purpose of providing general information about us. The site is not operated for advertising or marketing purposes. The material on this site should not be regarded as an offer to sell, or a solicitation of an offer to buy, any product of PMI. Such products are sold only in compliance with the laws of the particular jurisdictions in which they are sold.